Sort
40,608 grants matching “prostate cancer”
Molecular Imaging with FACBC PET-CT to Improve Post prostatectomy Radiotherapy
$400,052Ashesh Jani · Emory University · R01 · FY2015 · CA
Molecular Imaging with FACBC PET-CT to Improve Post prostatectomy Radiotherapy
$400,052Ashesh Jani · Emory University · R01 · FY2016 · CA
Inhibitor of Adrenal Steroid Synthesis for Cancer Treatment
$400,027Scott McNear Thacher · Orphagen Pharmaceuticals · R43 · FY2010 · CA
Collaborative Research: Heterogeneous Cancer Cell Mechanics Differentially Drives Mechanosensing and Migration
$400,000Adam J Engler · University Of California-San Diego · · FY2018 · ENG
MOLECULAR IMAGING CENTER PLANNING GRANT
$400,000Duke University · P20 · FY2001 · CA
CENTER FOR SINGLE PHOTO-EMITTING CANCER IMAGING AGENTS:
$400,000University Of Missouri-Columbia · P20 · FY2001 · CA
MOLECULAR IMAGING CENTER PLANNING GRANT
$400,000Washington University · P20 · FY2001 · CA
CENTER FOR SINGLE PHOTO EMITTING CANCER IMAGING AGENTS
$400,000University Of Missouri-Columbia · P20 · FY2000 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
$400,000Elizabeth L Travis · University Of Tx Md Anderson Can Ctr · U54 · FY2018 · CA
Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate Cancer
$400,000Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R44 · FY2024 · CA
The RCMI Program in Health Disparities Research at Meharry Medical College (Supplement)
$400,000Samuel E. Adunyah · Meharry Medical College · U54 · FY2020 · MD
CENTER FOR SINGLE PHOTO-EMITTING CANCER IMAGING AGENTS:
$400,000University Of Missouri-Columbia · P20 · FY2002 · CA
Cancer Center Support Grant (CCSG)
$400,000George J Weiner · University Of Iowa · P30 · FY2016 · CA
MOLECULAR IMAGING CENTER PLANNING GRANT
$400,000Washington University · P20 · FY2000 · CA
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)
$400,000Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2023 · CA
Beta Camera and Laparoscopic Probe for Surgical Cancer Removal.
$400,000Farhad Daghighian · Intra Medical Imaging, Llc · R44 · FY2009 · CA
Development of small molecule epigenetic therapeutics for prostate cancer
$400,000Zhi-Ping Liu · Raphael Pharmaceuticals Llc · R41 · FY2021 · CA
Genetic Epidemiology of Prostate Cancer
$400,000Stanford University · R01 · FY2005 · CA
Developing a Novel Biologic Therapy to Eradicate Brain Cancer and Brain Metastasis
$400,000Donald Davidson · Creative Biotherapeutics, Llc · R43 · FY2024 · CA
Targeting pancreatic cancer metastases with Targefrin
$400,000Carlo Baggio · Armida Labs, Inc. · R43 · FY2023 · CA
Development of a radiation-activatable nanoparticle for lung cancer therapy
$400,000Zhi Liu · Athna Biotech, Inc. · R41 · FY2021 · CA
Development of a novel, RNA-interference-based therapeutic to treat prostate cancer
$400,000Robert Schickel · Nuago Therapeutics Inc · R41 · FY2024 · CA
A decellularized porcine placenta matrix hydrogel for management of radiation-induced proctitis
$400,000Jian Jian Li · Briopryme Biologics, Inc. · R41 · FY2023 · CA
Phase 2 Study of Vascular-Targeted Prodrug (G-202) for the Treatment of Recurrent Glioblastoma
$400,000Santosh Kesari · Saint John'S Cancer Institute · R01 · FY2016 · FD
Phase 2 Study of Vascular-Targeted Prodrug (G-202) for the Treatment of Recurrent Glioblastoma
$400,000Santosh Kesari · University Of California, San Diego · R01 · FY2015 · FD